Ortoma AB Reaches Agreement with DePuy Synthes for its OTS (Ortoma Treatment Solutions) for Hip Replacement Therapy

We would like to congratulate Ortoma AB in reaching a global development and distribution agreement with DePuy Synthes for its OTS (Ortoma Treatment Solutions) for hip replacement surgery.

Linus Byström, CEO of Ortoma AB states: “We would like to thank MedWorld for being our advisor through this process and look forward to further successful strategic collaborations together”.

Ortoma will unveil its innovative solution for converting 2D x-ray images to 3D-models at ISTA in New York this week (September 27-30, 2023), where MedWorld will continue to support the company in its continuation to bring innovations to the world of Orthopedics. The Company will presents its scientific findings as well as offer demonstrations of the WOTS 2D to 3D Solutions through appointments only. Please reach out to Dave Sheppard to book your appointment for an exclusive demonstration.

Previous
Previous

MedWorld Advisors Hosts Webinar with Today’s Medical Developments Magazine - Watch Here!

Next
Next

Has MedTech Manufacturing Become Less Relevant in 2023?